GGrantIndex
Sort

39,280 grants matching leukemia

DRUG METABOLISM IN CHILDHOOD CANCER

$481,745
St. Jude Children'S Research Hospital · R37 · FY2003 · CA

Genetic analysis of mouse chromosome 11

$481,742
Monica Jean Justice · Baylor College Of Medicine · R01 · FY2008 · CA

Developmental Therapeutics

$481,718
Guido J. Tricot · Univ Of Arkansas For Med Scis · P01 · FY2008 · CA

Aberrant signaling in acute myeloid leukemia

$481,665
Alex Kentsis · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Assaying Tyrosine Kinase Activity: A New Paradigm

$481,662
University Of California Irvine · R33 · FY2005 · CA

PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN

$481,656
St. Jude Children'S Research Hospital · R01 · FY2005 · CA

Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-operative Treatment Trials

$481,560
Nola M. Hylton · University Of California, San Francisco · R01 · FY2009 · CA

Therapeutic targeting of glutamine metabolism in MDS

$481,538
Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Dysregulation of Innate Lymphoid Immunity in Acute Myeloid Leukemia

$481,484
Bethany Mundy-Bosse · Ohio State University · R01 · FY2024 · CA

Innate Immune Responses to Microbial Flora

$481,456
Eric G Pamer · Sloan-Kettering Inst Can Research · R01 · FY2017 · AI

Innate Immune Responses to Microbial Flora

$481,456
Eric G Pamer · Sloan-Kettering Inst Can Research · R01 · FY2016 · AI

Development of SHP2 inhibitors for targeted anti-cancer therapy

$481,271
Zhong-Yin Zhang · Purdue University · R01 · FY2017 · CA

Locus contraction at the Ig kappa locus

$481,250
Ann J Feeney · Scripps Research Institute, The · R56 · FY2016 · AI

HTLV-1 Particle Analysis and Gag Interactions

$481,250
Louis M Mansky · University Of Minnesota · R01 · FY2020 · GM

In Vivo Incorporation of Unnatural Amino Acids

$481,250
Peter G Schultz · Scripps Research Institute, The · R01 · FY2017 · GM

HTLV-1 Particle Analysis and Gag Interactions

$481,250
Louis M Mansky · University Of Minnesota · R01 · FY2019 · GM

Genome Core

$481,250
Charles G. Mullighan · St. Jude Children'S Research Hospital · U54 · FY2019 · CA

Targeting microRNAs to eradicate leukemia stem cells

$481,146
Ya-Huei Kuo · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA

Targeting IRAK1/4 in Myelodysplastic Syndromes

$481,139
Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · DK

Targeting IRAK1/4 in Myelodysplastic Syndromes

$481,139
Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · DK

In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer

$481,093
Ronald Jay Koenig · University Of Michigan At Ann Arbor · R01 · FY2014 · CA

ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies

$481,070
John C Byrd · Ohio State University · UG1 · FY2021 · CA

Innate Immune Responses to Microbial Flora

$481,023
Eric G Pamer · Sloan-Kettering Inst Can Research · R01 · FY2015 · AI

Molecular Pathology of t-AML

$481,023
James R Downing · University Of Chicago · P01 · FY2010 · CA

Flow Cytometric Evaluation of Biomarkers

$480,939
Maryalice Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA